ONCOZ — Oncozenge AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	PRESS	ARS	ARS	PRESS
Standards:	SAS	—	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10	51.2	29.1	12.6	3.86
Net Total Receivables	5.51	0.915	0.19	0.22	0.519
Prepaid Expenses
Total Current Assets	15.5	52.1	30	13.5	4.58
Net Property, Plant And Equipment	0	—	—	—	—
Net Intangible Assets
Other Long Term Assets
Total Assets	38.3	85.2	36.9	20.3	11.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.01	4.9	2.92	1.7	1.48
Total Long Term Debt
Total Debt
Total Liabilities	9.01	4.9	2.92	1.7	1.48
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	29.3	80.3	34	18.6	9.95
Total Liabilities & Shareholders' Equity	38.3	85.2	36.9	20.3	11.4
Total Common Shares Outstanding